13 results
Keyword Zinco Ossido Afom Remove keyword
-
List item
Referral: Gutal
zinc oxide, Article 33
Status: European Commission final decision, opinion/position date: 06/05/2015, EC decision date: 22/10/2015, Last updated: 26/11/2015based on a reference product, ZincoTec Zinc Oxide 100% Premix for … on a reference product, ZincoTec Zinc Oxide 100% Premix for … -
List item
Veterinary medicine European public assessment report (EPAR): Draxxin
tulathromycin, Pigs; Cattle; Sheep
Date of authorisation: 11/11/2003, Revision: 25, Authorised, Last updated: 24/09/2021 -
List item
Human medicine European public assessment report (EPAR): Wilzin
zinc, Hepatolenticular Degeneration
Date of authorisation: 12/10/2004, Revision: 11, Authorised, Last updated: 14/06/2019 -
List item
Referral: Zinc oxide
zinc oxide, Article 35
Status: European Commission final decision, opinion/position date: 16/03/2017, EC decision date: 26/06/2017, Last updated: 14/08/2017Reus (Tarragona) Spain ZINCOPREMIX 1000 mg/g Zinc oxide … Reus (Tarragona) Spain ZINCOPREMIX 1000MG/G πρόμιγμα … Reus (Tarragona) Spain ZINCOPREMIX 1000 mg/g premix pro medikaci … -
List item
Orphan designation: Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human alpha L-iduronidase gene for: Treatment of mucopolysaccharidosis type I
Date of designation: 17/01/2018, Positive, Last updated: 30/07/2019 -
List item
Orphan designation: Adeno-associated viral vector serotype 2/6 encoding zinc-finger nucleases and the human iduronate 2-sulfatase gene for: Treatment of mucopolysaccharidosis type II (Hunter's syndrome)
Date of designation: 17/01/2018, Positive, Last updated: 30/07/2019 -
List item
Orphan designation: Zinc acetate dihydrate for: Treatment of Wilson's disease
Date of designation: 31/07/2001, Expired, Last updated: 06/03/2015 -
List item
Orphan designation: Nitric oxide for: Treatment of cystic fibrosis
Date of designation: 15/10/2014, Positive, -
List item
Orphan designation: Sodium 3-[(4aR,6R,7R,7aS)-7-hydroxy-2-oxido-2-sulfanylidene-4a,6,7,7a-tetrahydro-4H-furo [3,2-d][1,3,2] dioxaphosphinin-6-yl]-2-bromo-6-phenyl-5H-imidazo[1,2-a]purin-9-one for: Treatment of retinitis pigmentosa
Date of designation: 19/03/2015, Positive, Last updated: 11/05/2015 -
List item
Orphan designation: Deuterium oxide for: Treatment of pancreatic cancer
Date of designation: 20/10/2004, Withdrawn, Last updated: 29/11/2005Hasnyαlmirigyrαk kezelιse Italian Ossido di deuterio Trattamento del … -
List item
Orphan designation: 4-Amino-1-[5-O-[(2R,4S)-2-oxido-4-(4-pyridinyl)-1,3,2-dioxaphosphorinan-2-yl]-ß-D-arabinofuranosyl]-2(1H)-pyrimidinone for: Treatment of hepatocellular carcinoma
Date of designation: 14/09/2007, Positive, Last updated: 22/01/2008 -
List item
Guidance documents
Last updated: 14/09/2021 -
List item
Public data from Article 57 database
Last updated: 02/06/2021